Gum arabic (GA) modifies paracellular water and electrolyte transport in the small intestine.
Previous experiments have shown that a soluble fiber, gum arabic (GA), enhances water, electrolyte, and glucose absorption in animal models of diarrhea. The mechanisms implicated in this effect have not been fully elucidated. This study examined the possibility that paracellular transport is modulated by luminal GA, resulting in an enhanced rate of absorption in the small intestine. This hypothesis was tested by 3-hr jejunal perfusions on anesthetized rats with solutions containing 140 mM NaCl, 5 mM KCl, and 2 microCi/liter (74 kBq) 3H2O, with either 2.5 g/liter GA [+GA] or in its absence [CTL], and one of the following agents, capable of altering paracellular transport: chenodeoxycholic acid at 0.5 mM (CDC), 2,4,6-triaminopyrimidine (TAP) at 20 mM, and protamine at 100 mg/liter (PTM). Sodium, potassium, net water, and unidirectional water movement were measured. The addition of GA increased sodium absorption in perfusions with CDC, TAP, or PTM only. Similar effects by GA on net water absorption rates were obtained in tissues permeabilized with CDC and PTM; however, GA added to TAP did not normalize the reduction caused by TAP. Although PTM did not alter net water absorption, addition of GA to perfusates with PTM enhanced absorption values above those of CTL. GA reversed the strong negative effects of CDC on potassium absorption but was ineffective in this regard with TAP and PTM. The data obtained with those reagents that affect paracellular transport and the histological evidence support the view that GA promotes net absorption by this route in the small intestine of normal rats.
Division of Perinatal-Neonatal Medicine, Schneider Children's Hospital at North Shore, Manhasset, New York 11030, USA.
Khalil U
KU
Rehman
Mark A
MA
Wingertzahn
Saul
S
Teichberg
Rita G
RG
Harper
Raul A
RA
Wapnir
D000818:Animals; D002463:Cell Membrane Permeability / Q000187:drug effects / Q000502:physiology; D002635:Chenodeoxycholic Acid / Q000494:pharmacology; D006170:Gum Arabic / Q000494:pharmacology*; D007408:Intestinal Absorption / Q000187:drug effects* / Q000502:physiology; D007583:Jejunum / Q000187:drug effects / Q000502:physiology; D008297:Male; D010477:Perfusion; D011188:Potassium / Q000378:metabolism; D011479:Protamines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D012964:Sodium / Q000378:metabolism; D014882:Water-Electrolyte Balance / Q000187:drug effects* / Q000502:physiology
D011479:Protamines; D011743:Pyrimidines; D002635:Chenodeoxycholic Acid; C012070:2,4,6-triaminopyrimidine; D006170:Gum Arabic; D012964:Sodium; D011188:Potassium